Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Related Keywords

Australia ,New Zealand ,India ,Giovanna Chandler ,Erika Schultz ,Stanleyc Erck ,Exchange Commission ,Linkedin ,World Health Organization ,European Commission ,Serum Institute Of India ,Nasdaq ,Novavax Inc ,Influenza Combination ,Chief Executive Officer ,Serum Institute ,World Health ,Financial Condition ,Novavax Annual Report ,Quarterly Reports ,Novavax ,Nc ,